Viewing Study NCT02983604


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2025-12-25 @ 7:08 PM
Study NCT ID: NCT02983604
Status: TERMINATED
Last Update Posted: 2019-08-07
First Post: 2016-12-02
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
Sponsor: Gilead Sciences
Organization: